Pharmaguy's Insights Into Drug Industry News
187.1K views | +30 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

DUIPs (Docs Under the Influence of #Pharma) Prescribe Opioids - Sales Reps Arrested

DUIPs (Docs Under the Influence of #Pharma) Prescribe Opioids - Sales Reps Arrested | Pharmaguy's Insights Into Drug Industry News | Scoop.it

The former district manager at Insys Therapeutics was irate. Several doctors were not prescribing enough of the company’s Subsys painkiller, which contains fentanyl, a powerful and addictive opioid.

 

So the manager, Jonathan Roper, wrote his sales team a pointed email, saying that “we invest a lot of time, money, blood, sweat, and tears on ‘our guys,’ ” — a reference to doctors who were paid to speak to other physicians about the medicine. “We hire only the best of the best to be a part of our speaker bureau and dropping script counts is what we get in return? This is a slap in the face to all of you and is a good indication as to why NONE of you are climbing in the rankings this quarter.”

 

Last Thursday, Roper and a former Insys sales rep named Fernando Serrano were arrested and charged with violating federal kickback laws. They allegedly ran a scheme between October 2013 and June 2015 in which doctors were paid thousands of dollars to participate in “sham educational programs” designed to boost Subsys prescriptions, according to Preet Bharara, the federal attorney for New York. The email from Roper two years ago was part of the indictment.

 

The arrests come amid intensifying controversy over the abuse and misuse of prescription painkillers and the extent to which these are appropriately prescribed. Federal health officials recently released new guidelines urging doctors to restrict their prescribing and some lawmakers want to pressure the Chinese government to toughen its laws to stop the illicit export to the United States.

 

This is not the first time that Insys has been named in connection with illegal activities designed to boost prescriptions for Subsys, which was approved in 2012 to treat cancer pain and generated nearly $330 million in sales last year (see here).

 

For instance, the company arranged “social gatherings at high-end restaurants in Manhattan” that were supposed to involve teaching doctors about Subsys but did not really involve any education. Doctors were enlisted to speak at these events, but often “lacked an appropriate audience of health care professionals,” according to the indictment. To make them appear legitimate, sign-in sheets were sometimes forged by adding names of doctors who did not attend.

 

Serrano and other reps received bonuses based, in large part, on the volume of Subsys prescriptions written by the doctors they were assigned to work with, according to the indictment. Serrano received a $70,000 bonus in the first quarter of 2014, which was the eighth-largest bonus among Insys reps at the time. In the fourth quarter of 2013, his bonus was about $100,000, the fifth-largest among Insys reps.

Pharma Guy's insight:

Is it any wonder that “Pharma Speaker Dinners are Popular with Docs”?; http://sco.lt/5dsmjR 

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Novartis Must Face a Kickback Lawsuit Filed by DOJ Over Sham Speaker Events at Smith & Wollensky & Hooters!

Novartis Must Face a Kickback Lawsuit Filed by DOJ Over Sham Speaker Events at Smith & Wollensky & Hooters! | Pharmaguy's Insights Into Drug Industry News | Scoop.it
A federal judge has ruled that Novartis must face a lawsuit in which the U.S. Department of Justice charged the drug maker with paying millions of dollars in kickbacks to physicians – including numerous lavish dinners – in order to persuade them to prescribe its medicines.


In the lawsuit, the feds maintain that Novartis boosted prescriptions by orchestrating “sham” speaker events, some of which were held at expensive restaurants, sports bars and fishing venues, where little or no direct connection to its drugs were discussed, according to court documents. And the drug maker allegedly paid various doctors to make the same presentation to the same group of doctors over a short period of time.


As an example, the lawsuit cites a July 2005 dinner at Smith & Wollensky in Washington, D.C., for $2,016 for three people, or $672 per person. There was also a May 2006 dinner at Nobu in New York, where a doctor was paid to speak, but only the physician, two of his friends – one of whom brought a girlfriend who was not a health care professional – and a Novartis sales reps had attended.


The lawsuit explains “in detail why the speaker events were shams and how they served as a vehicle for kickbacks,” U.S. District Court Judge Paul Gardephe wrote in a 90-page ruling. “Novartis has cited no case demonstrating that the government entities’ pleading of particular false claims is deficient.”


Pharma Guy's insight:


Smith & Wollensky wasn't the only restaurant Novartis treated Docs to. Novartis also Wined -- er, Beered -- and Dined Docs at Hooters! LOL!

 

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Wow! #Pharma Sales Rep & Paid Physician Paramour‎ Hatch Pain Med Kickback Scheme

Wow! #Pharma Sales Rep & Paid Physician Paramour‎ Hatch Pain Med Kickback Scheme | Pharmaguy's Insights Into Drug Industry News | Scoop.it

A former sales manager for Insys Pharmaceuticals, which manufactures a highly addictive painkiller (Sunsys Fentanyl - 100X more powerful than morphine) and is under investigation in multiple U.S. states, has pleaded guilty to charges of fraud.


Former Insys sales manager Natalie Reed Perhacs recently pleaded guilty to conspiracy to commit health care fraud including engaging in kickback schemes in the United States District Court for the Southern District of Alabama (Southern Division). 


Insys was the subject of a CNBC investigation in November which revealed that two physicians in Mobile, Alabama, Dr. Xiulu Ruan and Dr. John Couch, partners at a practice, received over $210,000 from Insys Therapuetics in 2013 and 2014 for things like speaking fees, travel and meals.


The agreement with the Insys sales rep, filed on Feb. 17 and obtained by CNBC, states that Perhacs was hired by Insys as a kickback to Dr. Ruan, who became fond of her and "went out of his way" to try to get her hired as a sales representative with a pharmaceutical company. 


In an e-mail sent on November 7, 2012, Dr. Ruan asked Perhacs,"Well, I want to ask you a personal question and hopefully you would not be offended. Are you involved with someone now? . . . You don't have to answer any of these if you do not feel comfortable."


The plea agreement states that Perhacs was not hired because of her knowledge or experience working with controlled substances like Subsys; but rather, she was hired to "induce, and in exchange for, Dr. Ruan continuing to prescribe Subsys."


"Perhacs had a strong financial incentive to do so, and to turn a blind eye to illegal kickbacks being paid by Company A [Insys] to Dr. Ruan and Dr. Couch. Despite earning a base salary of only $40,000.00 per year, commissions from off-label prescriptions written by Dr. Ruan and Dr. Couch resulted in Perhacs making over $700,000.00 between April 2013 and the doctors' arrests on May 20,2015."

Pharma Guy's insight:

Of course, this is not typical of mainstream Big Pharma.

more...
No comment yet.